StemGenex® Announces Newest Stem Cell Treatment for COPD Patients - WICU12 HD WSEE Erie, PA News, Sports, Weather and Events

StemGenex® Announces Newest Stem Cell Treatment for COPD Patients

  • Chris Lifestyle Category TESTMore>>

  • COPY-Chris Test 2

    Chris Test 2

    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>
  • Chris Test 1

    Chris Test 1

    Monday, February 6 2012 4:05 PM EST2012-02-06 21:05:06 GMT
    Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1Chris Test 1More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE StemGenex

StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells. These treatments are being studied with expertise by board certified MD's in the United States.

LA JOLLA, Calif., Feb. 11, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases, today announced the newest therapy to assist patients diagnosed with COPD.

Leaders in US Stem Cell Therapy, StemGenex (800) 609-7795

COPD affects an estimated 9-10% of the world's entire population and is the 4th most common cause of death in the United States.  StemGenex believes a new therapy delivering adipose derived mesenchymal cells directly to the inflamed lungs may reduce the complications associated with COPD including shortness of breath, coughing, heart problems and more. 

Direct lung targeting is the latest in a series of newly developed therapies StemGenex® has announced over the past few months for patients dealing with degenerative diseases such as Parkinson's, Alzheimer's, Multiple Sclerosis and of course COPD.  This targeted therapy is accomplished by nebulizing the stem cells down to a mist so that patients can painlessly breathe the stem cells directly into their lungs.  The goal of this new technique is to encourage more stem cells to travel directly to the inflamed tissue of the lungs.

Stem cell treatment studies are currently being offered by StemGenex to patients diagnosed with COPD and degenerative neurological diseases.  StemGenex takes a unique approach of compassion and empowerment while providing access to the latest stem cell therapies for degenerative neurological diseases including Parkinson's and Alzheimer's disease, stroke recovery and others.  Rita Alexander, founder of StemGenex and the company's first stem cell patient, insists that all patients be treated like they are one of our loved ones.  "Hope, compassion, and the relentless pursuit for an end to these diseases are our primary focus."

To find out more about stem cell therapy, contact StemGenex either by phone at (800) 609-7795 or email Contact@stemgenex.com.

Related Links
www.stemgenex.com

Multimedia Assets associated with this release:
Photo: http://photos.prnewswire.com/prnh/20140211/LA60980

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
3514 State St. Erie, PA 16508
Newsroom: (814)454-8812
Toll Free: 1(800)454-8812
Business offices: (814)454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
Mobile:
Mobile Site
Be sure to stay constantly updated with the power of WICU12 and WSEE at your fingertips
Free Android App
Free iPhone App
Free iPad App
Storm Tracker App
Droid
iPhone
iPad
All content © Copyright 2000 - 2014 WorldNow and WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com